Published online before print May 8, 2008

This Article Full Text (Rapid PDF) All Versions of this Article: ajpath.2008.060520v1 172/6/1520    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Ermini, F. V. Articles by Jucker, M. Search for Related Content PubMed PubMed Citation Articles by Ermini, F. V. Articles by Jucker, M. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information Stem Cells

Copyright © 2008 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2008.060520

Accepted for publication March 11, 2008.

Article

Neurogenesis and Alterations of Neural Stem Cells in Mouse Models of Cerebral Amyloidosis

Florian V. Ermini^*, Stefan Grathwohl^*, Rebecca Radde^*, Masohiro Yamaguchi, Matthias Staufenbiel, Theo D. Palmer^@, and Mathias Jucker^*@

Department of Cellular Neurology,* Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; Department of Neurosurgery, Stanford University School of Medicine, Stanford, California; Department of Physiology Graduate School of Medicine, University of Tokyo, Tokyo, Japan; Novartis Institutes for Biomedical Research Basel, Basel, Switzerland

^@ To whom correspondence should be addressed. E-mail: tpalmer{at}stanford.edu.

	Abstract

The hippocampus in Alzheimer's disease is burdened with amyloid plaques and is one of the few locations where neurogenesis continues throughout adult life. To evaluate the impact of amyloid-b deposition on neural stem cells, hippocampal neurogenesis was assessed using bromodeoxyuridine incorporation and doublecortin staining in two amyloid precursor protein (APP) transgenic mouse models. In 5-month-old APP23 mice prior to amyloid deposition, neurogenesis showed no robust difference relative to wild-type control mice, but 25-month-old amyloid-depositing APP23 mice showed significant increases in neurogenesis compared to controls. In contrast, 8-month-old amyloid-depositing APPPS1 mice revealed decreases in neurogenesis compared to controls. To study whether alterations in neurogenesis are the result of amyloid-induced changes at the level of neural stem cells, APPPS1 mice were crossed with mice expressing green fluorescence protein (GFP) under a central nervous system-specific nestin promoter. Eight-month-old nestin-GFP x APPPS1 mice exhibited decreases in quiescent nestin-positive astrocyte-like stem cells, while transient amplifying progenitor cells did not change in number. Strikingly, both astrocyte-like and transient-amplifying progenitor cells revealed an aberrant morphologic reaction toward congophilic amyloid-deposits. A similar reaction toward the amyloid was no longer observed in doublecortin-positive immature neurons. Results provide evidence for a disruption of neural stem cell biology in an amyloidogenic environment and support findings that neurogenesis is differently affected among various transgenic mouse models of Alzheimer's disease.